PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells
The overexpression of Polo-like kinase 1 (Plk1) promotes various cancers in humans; sporadic evidence suggests Plk1 could act as a tumor suppressor but the molecular basis for this effect are unclear. Here the authors show that Plk1 inhibition augments the tumorigenic capacity of a dominant-negative...
Guardado en:
Autores principales: | Monika Raab, Mourad Sanhaji, Yves Matthess, Albrecht Hörlin, Ioana Lorenz, Christina Dötsch, Nils Habbe, Oliver Waidmann, Elisabeth Kurunci-Csacsko, Ron Firestein, Sven Becker, Klaus Strebhardt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a03432a0fac04ac49c63a7cf0e5451dc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immune adaptor SKAP1 acts a scaffold for Polo-like kinase 1 (PLK1) for the optimal cell cycling of T-cells
por: Monika Raab, et al.
Publicado: (2019) -
Vertaileva aikatutkimus Risutec APC- ja Bracke-istutuslaitteista
por: Tiina Laine, et al.
Publicado: (2015) -
METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N 6-methyladenosine-dependent YTHDF binding
por: Wei Wang, et al.
Publicado: (2021) -
Identification of the PLK2-dependent phosphopeptidome by quantitative proteomics [corrected].
por: Cinzia Franchin, et al.
Publicado: (2014) -
APC2 controls dendrite development by promoting microtubule dynamics
por: Olga I. Kahn, et al.
Publicado: (2018)